Inova Diagnostics, Inc.: FDA filings under this applicant name
FDA lists 136 510(k) clearances under the applicant name “Inova Diagnostics, Inc.” (first 1988, latest 2026), plus 2 De Novo decisions, across 41 product codes in 3 review panels. Median 510(k) review time under this name: 93 days. Since 2017 the median was 275 days, against 194 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Werfen, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 2 | 300 |
| 2013 | 3 | 225 |
| 2014 | 1 | 417 |
| 2015 | 8 | 261 |
| 2016 | 3 | 260 |
| 2017 | 4 | 264 |
| 2018 | 2 | 130 |
| 2019 | 1 | 90 |
| 2020 | 1 | 423 |
| 2021 | 2 | 558 |
| 2022 | 0 | — |
| 2023 | 1 | 711 |
| 2024 | 1 | 809 |
| 2025 | 0 | — |
| 2026 | 1 | 410 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Inova Diagnostics, Inc. took a median 275 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 194 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LLL | Extractable Antinuclear Antibody, Antigen And Control | 37 | 37 |
| MVM | Autoantibodies, Endomysial(Tissue Transglutaminase) | 12 | 12 |
| MID | System, Test, Anticardiolipin Immunological | 9 | 9 |
| MOB | Test System, Antineutrophil Cytoplasmic Antibodies (Anca) | 8 | 8 |
| MST | Antibodies, Gliadin | 8 | 8 |
| MSV | System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) | 7 | 7 |
| DHN | Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control | 4 | 4 |
| DHR | System, Test, Rheumatoid Factor | 4 | 4 |
| NHX | Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp) | 4 | 4 |
| LJM | Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls | 3 | 3 |
Plus 31 more product codes.
Review panels
- Immunology (128)
- Microbiology (9)
- Clinical Chemistry (1)
Most recent Inova Diagnostics, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K243979 | Aptiva APS IgA Reagent | MSV | 2026-02-06 | 410 |
| K223093 | Aptiva APS IgG Reagent; Aptiva APS IgM Reagent | MID | 2024-12-17 | 809 |
| K213403 | Aptiva CTD Essential Reagent | LLL | 2023-09-29 | 711 |
| K200230 | Aptiva Celiac Disease IgG Reagent | MVM | 2021-08-26 | 574 |
| K193604 | Aptiva Celiac Disease IgA Reagent | MVM | 2021-06-16 | 541 |
| K192916 | NOVA Lite DAPI dsDNA Crithidia luciliae Kit | KTL | 2020-12-11 | 423 |
| K190088 | QUANTA Flash RF IgM Reagents, QUANTA Flash RF IgA Reagents | DHR | 2019-04-17 | 90 |
| K180971 | QUANTA Flash Calprotectin and Fecal Extraction Device | NXO | 2018-10-16 | 186 |
| K180975 | QUANTA Flash HMGCR Reagents | LLL | 2018-06-25 | 73 |
| K170993 | QUANTA Flash Calprotectin Reagents, QUANTA Flash Calprotectin Calibrators, QUANTA Flash Calprotectin Controls, QUANTA Flash Calprotectin Extraction Buffer | NXO | 2017-12-22 | 263 |
126 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN140039 | De Novo | Automated Indirect Immunofluorescence Microscope And Software-Assisted System For Clinical Use | 2015-04-09 |
| DEN000007 | De Novo | Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae) | 2000-08-16 |
Recalls
4 product recalls in 3 recall events; 0 initiated in the last five years. Most recent: 2018-01-26.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Inova Labs, Inc. (3 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Inova Diagnostics, Inc.?
FDA lists 136 510(k) clearances under the applicant name “Inova Diagnostics, Inc.” (first 1988, latest 2026), plus 2 De Novo decisions, across 41 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Inova Diagnostics, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Inova Diagnostics, Inc. is 93 days. Since 2017: 275 days, versus 194 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Inova Diagnostics, Inc.?
The most frequent FDA product codes under this applicant name are LLL (Extractable Antinuclear Antibody, Antigen And Control, 37); MVM (Autoantibodies, Endomysial(Tissue Transglutaminase), 12); MID (System, Test, Anticardiolipin Immunological, 9).
Next steps
- See all 136 Inova Diagnostics, Inc. clearances with predicates and recalls
- Run predicate analysis for product code LLL, Inova Diagnostics, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.